We are live on
!
Find out more
NME
Notis-McConarty Edward Portfolio holdings
AUM
$201M
1-Year Est. Return
18.67%
This Fund
S&P 500
This Quarter
Est. Return
+3.77%
1 Year Est. Return
+18.67%
3 Year Est. Return
+65.19%
5 Year Est. Return
+89.79%
10 Year Est. Return
+322.21%
AUM
$254M
AUM Growth
+$1.44M
(+0.57%)
Cap. Flow
-$4.03M
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
41.46%
Holding
92
New
3
Increased
8
Reduced
56
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$1.07M |
| 2 |
Ball Corp
BALL
|
+$1.04M |
| 3 |
Carrier Global
CARR
|
+$980K |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$797K |
| 5 |
Walmart Inc
WMT
|
+$208K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$1.34M |
| 2 |
Nike
NKE
|
+$1.16M |
| 3 |
NVIDIA
NVDA
|
+$1.08M |
| 4 |
Advanced Micro Devices
AMD
|
+$333K |
| 5 |
CVS Health
CVS
|
+$291K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.77% |
| 2 | Healthcare | 19.93% |
| 3 | Industrials | 12.8% |
| 4 | Consumer Discretionary | 9.06% |
| 5 | Consumer Staples | 6.81% |
Similar funds
SIA
LS
ACM
FB
MPM
LWMI
RCM
CIG
Notis-McConarty Edward's Q2 2024 Portfolio in Review
As of Q2 2024, Notis-McConarty Edward held 92 positions worth $254M, up 0.57% from $253M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Notis-McConarty Edward's Q2 2024 filing shows 3 new, 8 increased, 56 reduced and 2 closed positions. Its largest new stake was McCormick & Company Non-Voting: 10,945 shares worth $776K. The largest sale was Novartis, an estimated $1.34M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.
- Notis-McConarty Edward's largest Q2 2024 buy was McCormick & Company Non-Voting: 10,945 shares worth $776K.
- Notis-McConarty Edward added most to Vertex Pharmaceuticals in Q2 2024, an estimated $1.07M increase.
- Notis-McConarty Edward's biggest Q2 2024 reduction was Novartis, cutting an estimated $1.34M.
- Notis-McConarty Edward fully exited Eli Lilly in Q2 2024, selling an estimated $272K.
- Notis-McConarty Edward's ten largest holdings make up 41% of its $254M portfolio in Q2 2024.
- Notis-McConarty Edward opened 3 new positions and closed 2 in Q2 2024.
- Notis-McConarty Edward's portfolio value rose 0.57% quarter-over-quarter to $254M.
Based on Notis-McConarty Edward's 13F filing for Q2 2024, filed 12 Aug 2024.